Bioinformatics.org
|
|
Research
|
Online databases
Online analysis tools
Online education tools
|
Development
|
|
Forums
|
News & Commentary
Jobs Forum (Career Center)
|
|
News & Commentary - Message forums
|
|
|
|
The Blade: Biotech Industry at Stake as High Court Weighs Human Gene Patent
Submitted by J.W. Bizzaro; posted on Friday, April 12, 2013
|
EXCERPT
"The case, which the court will decide by June, is splitting the medical community. Trade groups for the biotechnology, agriculture and drug industries are siding with Myriad. They say gene patents have led to valuable treatments, including Amgen Inc.'s Epogen anemia drug and synthetic insulin developed by Genentech Inc., now part of Roche Holding AG.
"Doctor groups such as the American Medical Association are backing the challengers to the patents. They have partial support from the Obama administration, which is urging the court to uphold parts of Myriad's patents and void other aspects."
|
|
Expanded view | Monitor forum | Save place
Start a new thread:
You have to be to post a reply.
|
|